Evidence-based Guidelines for the Use of Albumin Products Japan Society of Transfusion Medicine and Cell Therapy

摘要

1.Introduction2.Types of Albumin Products and Assessment of Administration3.Hypoalbuminemia and Indications of Albumin4.Effects of Different Assays on Serum Albumin Levels5.Benefits and Recommendations for Albumin Use by Pathological Condition(i)Hemorrhagic shock(ii)Severe sepsis(iii)Ascites secondary to liver cirrhosis(iv)Nephritic syndrome with refractory edema or pulmonary edema(v)Extracorporeal circulation with unstable hemodynamics(vi)Therapeutic plasma exchange not requiring the replacement of coagulation factors(vii)Severe burns(viii) Pulmonary edema or marked edema due to hypoproteinemia(ix)Markedly decreased circulating plasma volume(x)Cerebral ischemia (head injury)(xi)Heart surgery with cardiopulmonary bypass(xii)Hypoalbuminemia with stable hemodynamics during the perioperative period(xiii) Pregnancy-induced hypertension(xiv) Inflammatory bowel disease(xv)Nutritional support as a source of protein(xvi)Terminally ill patients(xvii) Pathological conditions that are not eligible for other plasma expanders(vii)Severe burns(viii) Pulmonary edema or marked edema due to hypoproteinemia(ix)Markedly decreased circulating plasma volume